A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
Clinical trial NCT04875754 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04875754
- Sponsor
- ICM Biotech Australia Pty Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-17
- Primary completion
- 2026-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.